Dr. Tse Wen Chang, Chairman and CEO of Immunwork, and Dr. Art Hsing-Mao Chu, CEO of T-E Meds, have been invited to World ADC Asia 2024 in Korea. They will share updates on our innovative tech platforms and drug candidates, with a special focus on our ADC technologies. Dr. Chu will present “Exploring ADCs With … Continue reading Join our presentation at the World ADC Asia 2024 Conference